RoC has nearly 70 years of history. The useful question is what that history allows the company to do next.
The company was founded in Paris in 1957 by a Doctor of Pharmacy.
It has partnered with dermatologists on research since 1960.
It became the first to stabilize retinol in a skincare product in 1995.
Today, RoC’s formulas have been evaluated in more than 250 clinical efficacy and tolerance studies.
Over the past five decades, nearly 50 patents have been awarded on RoC innovations. As of 2026, six are active and five of those six relate to retinol.
Those are not simply heritage points.
They give RoC a base from which to move into larger questions about skin and aging.
RoC returned to France in 2024.
In 2025, it formed its Longevity Council and established a research fund with a leading U.S. university to study the biology of aging.
In 2026, RoC’s Mind the Gap study, a survey of 6,818 women ages 35 and over across 12 countries, found that they felt nine years younger than their chronological age on average.
Retinol Correxion® Line Smoothing Triple Serum also launched with a clinical study showing a visible 7-year reduction in skin age in 4 weeks†.
†Clinical assessment of crow’s feet and under-eye wrinkles: 29 subjects, total study duration 12 weeks, results after 1 month.
Together, those moves show where the company is heading.
RoC is taking a company built on anti-aging skincare deeper into the science and business of longevity, while continuing to compete on the things that built the brand in the first place: formulation, clinical evidence, dermatologist collaboration and retinol expertise.



